Malaria Vaccine Green-Lit by the WHO

In Travel Vaccine News by Travel Vaccine

The World Health Organization (WHO) announced today it is recommending widespread use of GSK’s Mosquirix RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and other regions with moderate to high P. falciparum malaria transmission. 
The WHO recommendation is based on results from an ongoing pilot program in Ghana, Kenya, and Malawi that has reached more than 800,000 children since 2019.
To date, more than 2.3 million doses of the vaccine have been administered in African countries.

Read More